大北農(002385.SZ):子公司的轉基因玉米DBN9936再次獲得美國FDA關於產品安全性和營養性評估回函
格隆匯12月17日丨大北農(002385.SZ)公佈,2021年9月30日,公司收到信息,公司控股子公司北京大北農生物技術有限公司自主研發的抗蟲耐除草劑轉基因玉米DBN9936經過一系列程序,完成美國FDA的安全評價,獲得FDA的轉基因產品上市前食用安全批准。
公司控股子公司北京大北農生物技術有限公司於2018年7月9日向美國FDA提交關於耐兩種除草劑轉化體DBN9858玉米的安全和營養評估摘要,並於2019年3月19日、3月29日和7月1日,以及2020年12月17日提交了補充信息。
2021年12月17日,美國FDA官方公佈最終意見:DBN9858玉米在組成、安全性和其他相關方面與目前市場上的玉米沒有實質性差異,而且轉基因DBN9858玉米不存在需要FDA進行上市前審查或批准的問題。
大北農控股子公司的轉基因玉米又一產品獲得美國FDA的批准,印證了大北農轉基因作物研發與生物安全管理水平已達到了國際水平。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.